MDNews - Mid Penn

Insights 2020

Issue link: https://viewer.e-digitaledition.com/i/1255745

Contents of this Issue

Navigation

Page 8 of 15

This illustration shows the placement of the Edwards SAPIEN Transcatheter Heart Valve through a transfemoral approach, which is performed through an incision in the leg or slightly higher. The valve is delivered to the aorta via guide wire. procedure is about 2-5%. In the eight plus years WellSpan physicians have been performing TAVRs, their patients' stroke rate is consistently less than 1%. Since the inception of TAVR, WellSpan physicians were involved with many of the pivotal research trials that helped bring this new therapy to approval by the FDA. "WellSpan remains on the forefront of medical technology by staying involved in multiple current local, national and internationa l tria ls involving TAV R and other structural heart therapies," Dr. Harvey says, "which enables us to offer world-class, cutting-edge technology right here in our communities." WellSpan's Structural Heart program requires rigorous collaboration between Dr. Harvey's team and other providers to ensure patient safety. " We're confident in the procedures we perform, but we're a lso appropriately cautious," Dr. Ha r vey says. " We're in consta nt communication w ith other centers to be certain we're a ll learning and continuing to improve these cutting edge therapies." "Regionally, nationally and now inter- nationally, our hospital has been renowned for continuing to stay on the leading edge of technology and advancing structural heart procedures," Dr. Harvey says. To learn more about how WellSpan is advancing TAVR and other structural heart procedures, visit wellspan.org/hv or call (717) 812-3617. n TAVR is a non-surgical procedure that involves the insertion of a catheter into the patient's femoral artery, a vessel that provides blood to the leg. Through this catheter, a new valve is delivered to the heart through the aorta. The new valve consists of bovine or porcine heart tissue supported by an expandable metal cage. This new valve is then placed inside the diseased valve to replace the old one with a new and normally functioning valve. Because of the minimal invasiveness of the procedure, most patients are able to go home within 1 to 3 days after the procedure. Patients who receive this new valve usually feel much better within a few days. M D N E W S . C O M /// M D N E W S M i D - P E N N ■ 2 0 2 0 0 9

Articles in this issue

Links on this page

Archives of this issue

view archives of MDNews - Mid Penn - Insights 2020